Correction: RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

Authors :: Kai Wang
Sergey Ryzhov
Simon Mallal
Henry L. Gomez
Sathana Dushyanthen
Peter Savas
Carlos L. Arteaga
Susan E. Combs
Franco Doimi
Roman Yelensky
Sherene Loi
Vincent A. Miller
Monica V. Estrada
Phil Stephens
Melinda E. Sanders
Carsten Denkert
Phillip K. Darcy
Rebecca S. Cook
Violeta Sanchez
David L. Rimm
Justin M. Balko
Jennifer M. Giltnane
Roberto Salgado
Mark A. Pilkinton
Paul A. Beavis
Source :: Clinical cancer research : an official journal of the American Association for Cancer Research. 25(4)
Publication Year :: 2019

Subjects :: Cancer Research
biology
business.industry
Ras mapk
Tumor-infiltrating lymphocytes
Immune checkpoint inhibitors
Cancer
medicine.disease
Article
Oncology
PD-L1
biology.protein
Cancer research
Medicine
business
Triple-negative breast cancer

ISSN :: 15573265
Volume :: 25
Issue :: 4
Database :: OpenAIRE
Journal :: Clinical cancer research : an official journal of the American Association for Cancer Research
Accession number :: edsair.doi.dedup.....0e736d3b926b63adae242d319de7a7fd

Tools